过去一年中添加的文章,按日期排序

Long-term efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion thyroid carcinoma (TC).

ME Cabanillas, JJ Lin, MS Brose, RS McDermott… - 2024 - ascopubs.org
65 天前 - … Laro is the first-in-class, highly selective, central nervous system (CNS)-active
TRK inhibitor approved for tumor-agnostic use in pts with TRK fusion cancer based on overall …

Is Surgery Always Necessary for Larger Malignant and Suspicious Thyroid Nodules?

A Kotwal - Clinical Thyroidology®, 2024 - liebertpub.com
93 天前 - … of thyroid carcinoma has … thyroid cancer, including active surveillance for DTCs <1
cm, 1,2 hemithyroidectomy for intrathyroidal, nonmetastatic DTCs <4 cm, and selective use of …

PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β‐catenin signaling pathway

J Deng, Y Cheng, H Li, X He, S Yu, J Ma, X Li, J Chen… - Endocrine, 2024 - Springer
163 天前 - … The selective AKT inhibitor MK2206 was noted to reverse the increased expression
of p-AKT (ser473) and p-GSK3α/β (ser21/9) induced by PFKFB3 overexpression. The level …

RET Kinase Inhibitors for the Treatment of RET-altered Thyroid Cancers: Current Knowledge and Future Directions

S Hamidi, MI Hu - Annales d'endocrinologie, 2024 - Elsevier
175 天前 - … • The neoadjuvant use of selective RET inhibitors is a promising approach in locally
thyroid carcinoma, while RET fusions are identified in 5-10% of papillary thyroid carcinomas

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers

AL Sarvestani, J Lambdin, M Hu, M Cabanillas… - Annals of surgical …, 2024 - Springer
194 天前 - thyroid cancers (excluding anaplastic thyroid carcinoma) remain undefined. About
60% of medullary thyroid … Little is currently known regarding the safety of selective RET …

Selpercatinib-induced hepatotoxicity: A rare case report

G Liang, J Lin, D Zhang - American Journal of Clinical …, 2023 - academic.oup.com
275 天前 - … ) is a highly selective rearranged during transfection (RET) … thyroid carcinoma or
non-small cell lung carcinoma. Among … who had medullary thyroid carcinoma with RET M918T …

SAT574 Thyroglossal Duct Papillary Thyroid Cancer With Normal Eutopic Thyroid Gland: A Management Dilemma

H Belal, JT Batch, GY Gandhi - Journal of the Endocrine Society, 2023 - academic.oup.com
302 天前 - … on treatment of thyroid carcinomas arising from … thyroid lobectomy or pyramidal
lobe resection 3) SP with total or near total thyroidectomy in all patients and 4) SP and selective

[HTML][HTML] NEWS/EVENT

MS Berkoben - dit.edu.ng
310 天前 - … Sampling a multinodular goiter should be ented, and each level should be carefully
dissected limited to one or two sections selectively taken (see Chapter 10). Each lymph …

[HTML][HTML] Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study

S Murray, V Subbiah, SI Sherman, S Péloquin, A Sireci… - Thyroid Research, 2023 - Springer
354 天前 - … The discovery of driver oncogenes for thyroid carcinomas … have altered the treatment
algorithm in thyroid cancer (TC), … number of selective RET inhibitors approved for use, this …